Zimmer Biomet Holdings, Inc. (ZBH) Q1 2022 Earnings Results

Zimmer Biomet Beats on EPS, Stock Up 0.02%

Zimmer Biomet's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the lack of revenue data and guidance leaves some uncertainty about future performance. The stock's slight increase of 0.02% suggests that investors are reacting positively to the EPS beat, but they may be waiting for more information on revenue and future outlook.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.61	N/A	+15.33%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about the company's performance. They acknowledged challenges but emphasized their commitment to overcoming them.

Management highlighted strong performance in key product lines.

They noted ongoing challenges in the supply chain but expressed confidence in future growth.

Zimmer Biomet Beats on EPS, Stock Up 0.02%

Key numbers

Management commentary

Zimmer Biomet Holdings, Inc.

More earnings this week

Zimmer Biomet Beats on EPS, Stock Up 0.02%

Key numbers

Management commentary